Infinity to Participate in Three Conferences in February
Citi Global Healthcare Conference 2013 Leerink Swann Healthcare Conference
2013 RBC Capital Markets Global Healthcare Conference 2013
CAMBRIDGE, Mass. -- February 6, 2013
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the
following conferences in February 2013:
*2013 Leerink Swann Healthcare Conference, New York, February 13, 2013, at
9:00 a.m. ET
*Citi 2013 Global Healthcare Conference, New York, February 25, 2013, at
9:35 a.m. and 2:15 p.m. ET (panel discussions)
*2013 RBC Capital Markets Global Healthcare Conference, New York, February
27, 2013, at 10:00 a.m. ET
A live webcast of each of Infinity's presentations will be accessible on the
“investors/media” section of the company's website, www.infi.com, and will be
available for 30 days following each event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative drug discovery and development company seeking to
discover, develop and deliver to patients best-in-class medicines for diseases
with significant unmet need. Infinity combines proven scientific expertise
with a passion for developing novel small molecule drugs that target emerging
disease pathways. Infinity’s programs focused on the inhibition of
phosphoinositide-3-kinase and heat shock protein 90 are evidence of its
innovative approach to drug discovery and development. For more information on
Infinity, please refer to the company’s website at www.infi.com.
Infinity Pharmaceuticals, Inc.
Kate Murray, 617-453-1179
Press spacebar to pause and continue. Press esc to stop.